Self-reported quality of life in patients with retinitis pigmentosa and maculopathy of Bothnia type.
OBJECTIVE
To assess vision-related quality-of-life subscales with objective measurements of visual function in patients affected with retinitis pigmentosa of Bothnia type (BD).


METHODS
Forty-nine patients answered the NEI-VFQ-25 questionnaire. High- and low-contrast distance acuity (VA), near VA, and visual fields (VF) were measured. Weighted VA (WVA) and low-contrast (10%) VA (WLCVA), binocular VF areas, and central scotoma were calculated. Adjusted mean subscale scores were calculated and associations analyzed.


RESULTS
Subscale scores for general, far, and near vision, social functioning, and color vision were lowest while general health, ocular pain, and mental health were highest in the BD phenotype. The correlations were substantial and similar for WVA, WLCVA, and near vision. The degree of measured VF impairment had few associations with the different adjusted subscale scores.


CONCLUSIONS
The NEI VFQ-25 subscales were well associated with clinical vision measures depending on VA. The progression of VF defects typical for the BD phenotype does not seem to affect the self-perceived quality of life, which might indicate adaptability to this type of progressive VF loss. The BD phenotype has a significant impact on multiple domains of daily life, but there are no signs of accelerating depression related to the increasing visual impairment.
Burstedt
Marie S I
MS
Department of Clinical Sciences/Ophthalmology, University of Umeå, Sweden.
Mönestam
Eva
E
Arch Ophthalmol. 1998 Feb;116(2):227-33
9488276
Arch Ophthalmol. 2001 Feb;119(2):260-7
11176989
Ophthalmology. 1996 Mar;103(3):398-405
8600415
Retina. 2005 Apr-May;25(3):317-23
15805909
Invest Ophthalmol Vis Sci. 2008 Jul;49(7):3172-7
18344446
Vision Res. 2003 Nov;43(24):2559-71
13129542
Doc Ophthalmol. 2008 May;116(3):193-205
17922155
Clin Genet. 2001 Jun;59(6):424-9
11453974
Ophthalmology. 1994 Jun;101(6):1131-40; discussion 1140-1
8008355
Am J Hum Genet. 2002 Apr;70(4):955-64
11868161
Invest Ophthalmol Vis Sci. 1999 Apr;40(5):995-1000
10102298
Arch Ophthalmol. 1998 Apr;116(4):514-20
9565052
Arch Ophthalmol. 2001 Jul;119(7):1050-8
11448327
Ophthalmology. 2001 Oct;108(10):1893-900; discussion 1900-1
11581068
Br J Ophthalmol. 1998 Dec;82(12):1372-6
9930266
Ophthalmology. 1998 May;105(5):795-803
9593378
Arch Ophthalmol. 1997 Jan;115(1):53-9
9006425
Nat Genet. 1997 Oct;17(2):198-200
9326942
Invest Ophthalmol Vis Sci. 1999 Apr;40(5):1000-4
10102299
Ophthalmology. 2004 Dec;111(12):2259-64
15582083
Ophthalmology. 1998 Jun;105(6):1069-75
9627658
Arch Ophthalmol. 1998 Nov;116(11):1496-504
9823352
Am J Ophthalmol. 1991 Mar 15;111(3):372-4
2000910
J Am Geriatr Soc. 1996 Feb;44(2):181-4
8576509